Meitav Investment House’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-782	Closed	-$269K	–	547
2023 Q1	$269K	Hold	782	–	–	﹤0.01%	328
2022 Q4	$234K	Hold	782	–	–	﹤0.01%	340
2022 Q3	$234K	Hold	782	–	–	﹤0.01%	338
2022 Q2	$230K	Buy	+782	New	+$230K	﹤0.01%	319